Stelara 90MG/ML SYR 1S
Ended Awarded
- Contract number
- SPE2DX25FKVXC
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $48,750
Award facts
- Contract value 100% obligated
- $48,749.85 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Defense Logistics Agency, through its Medical Supply Chain division, awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Stelara 90mg/ml syringes. This firm fixed-price delivery order, valued at $48,749.85, carries an ultimate completion date of September 5, 2025, and was awarded on August 15, 2025. The delivery order does not utilize a set-aside designation, and performance will occur at the vendor's Park Ridge, Illinois location. Stelara is a branded immunosuppressant biologic used to treat conditions such as psoriasis, psoriatic arthritis, and inflammatory bowel disease, reflecting the Defense Logistics Agency's continued procurement of specialty pharmaceutical products for military health facilities.
This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency's SPE2DB program, a $500 million vehicle valid through November 2026 that enables the agency to procure an extensive portfolio of pharmaceutical products including prescription medications, biologics, and medical consumables to support Department of Defense healthcare sites worldwide. DMS Pharmaceutical Group has maintained a robust presence in federal pharmaceutical procurement since its SAM.gov registration in 2001, consistently competing effectively through its woman-owned small business status while distributing branded and generic medications, vaccines, and specialty pharmaceuticals to military healthcare systems across the nation.
Quick answers
Who was awarded contract SPE2DX25FKVXC?
SPE2DX25FKVXC was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on August 15, 2025.
How much is contract SPE2DX25FKVXC worth?
The government has obligated $48,750 on SPE2DX25FKVXC.
Is contract SPE2DX25FKVXC an order under another contract?
Yes. SPE2DX25FKVXC is a delivery order under SPE2DX15D9628, an indefinite delivery contract.
Was contract SPE2DX25FKVXC competed?
The extent of competition for SPE2DX25FKVXC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award